Xiaoying, Zhao
Wanjing, Feng
Qirong, Geng
Mingzhu, Huang
Zhe, Zhang
Jinsi, Chen
Xuedan, Sheng
Xiaodong, Zhu
Weijian, Guo
Article History
Received: 5 February 2026
Accepted: 19 March 2026
First Online: 21 April 2026
Declarations
:
: The authors declared no conflict of interest.
: This trial was approved by Ethics Committee of Fudan University Shanghai Cancer Center approved the protocol (2208259-6), and conducted in accordance with the Declaration of Helsinki, good clinical practice (GCP) guidelines, and applicable local regulations. All patients provided consent for data collection and analysis.